Anebulo Pharmaceuticals plans reverse stock split to go private

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Anebulo Pharmaceuticals plans reverse stock split to go private

Anebulo Pharmaceuticals Approves Plan to Terminate Registration of Its Common Stock

July 23, 2025 8:00 AM EDT

AUSTIN, Texas--(BUSINESS WIRE)-- Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the Company or Anebulo), today announced that a Special Committee of independent directors has recommended, and its Board of Directors (the Board) has approved, as part of a going private transaction, a reverse stock split at a ratio of not less than 1-for-2,500 and not greater than 1-for-7,500 (the Range), with the exact ratio to be set within the Range without further approval or authorization of the Companys stockholders and... More